AbCellera Biologics Inc vs Goodyear Tire & Rubber Co — how do they compare? AbCellera Biologics Inc trades at $8.92 (market cap $2.85B), while Goodyear Tire & Rubber Co trades at $6.07 (market cap $1.74B). The key difference: AbCellera Biologics Inc is the larger of the two by market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Goodyear Tire & Rubber Co nearer its low. Which is the better fit depends on your goals.
| ABCL | GT | |
|---|---|---|
Market Cap | $2.85B | $1.74B |
Sector | Health | Consumer Cyclical |
52-Week High | $9.76 | $10.54 |
52-Week Low | $2.78 | $5.58 |
Enterprise Value | $2.45B | $9.09B |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.
Read more on GT →